Erythroderma lethal congenital
Erythroderma Lethal Congenital is a rare and severe skin disorder that affects newborns. This condition is characterized by widespread redness and scaling of the skin, which occurs due to various underlying genetic abnormalities. The term "erythroderma" refers to the redness of the skin, while "congenital" indicates that the disorder is present at birth.
Causes[edit | edit source]
Erythroderma Lethal Congenital is caused by genetic mutations that affect the skin's ability to function normally. These mutations can be inherited from the parents or occur spontaneously. The specific genes involved can vary, leading to different subtypes of the condition.
Symptoms[edit | edit source]
The primary symptom of Erythroderma Lethal Congenital is the widespread redness and scaling of the skin that covers most of the body. This can lead to severe complications, including:
- Infections due to the compromised skin barrier
- Difficulty in regulating body temperature
- Excessive loss of fluids, leading to dehydration
- Potential for metabolic disturbances
Diagnosis[edit | edit source]
Diagnosis of Erythroderma Lethal Congenital is primarily based on the clinical presentation of the skin at birth. Genetic testing may be conducted to identify the specific mutation(s) responsible for the condition. Prenatal diagnosis may be possible in families with a known history of the disorder.
Treatment[edit | edit source]
Treatment for Erythroderma Lethal Congenital is supportive and aims to manage symptoms and prevent complications. This may include:
- Intensive skincare to protect and moisturize the skin
- Measures to prevent infection
- Support for nutritional needs and fluid balance
- Monitoring and managing potential metabolic disturbances
Due to the severity of the condition, a multidisciplinary approach involving dermatologists, pediatricians, and other specialists is often necessary.
Prognosis[edit | edit source]
The prognosis for infants with Erythroderma Lethal Congenital is generally poor, with a high risk of mortality in the early stages of life. The severity of the condition and the presence of complications such as infections significantly affect the outcome.
See Also[edit | edit source]
Erythroderma lethal congenital Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD